Satsuma Pharmaceuticals Inc (STSA)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-06-08 | 2023-06-08 | B Purchase |
Shin Nippon Biomedical Laboratories, Ltd. Large shareholder |
8,423,732
+inf%
0.91USD 7,665,596 |
8,423,732 +inf% | 0.91 | USD 7,665,596 | |
| 2023-06-08 | 2023-06-06 | B Purchase |
Shin Nippon Biomedical Laboratories, Ltd. Large shareholder |
22,053,581
+inf%
0.91USD 20,068,759 |
22,053,581 +inf% | 0.91 | USD 20,068,759 | |
| 2023-06-08 | 2023-06-06 | B Purchase | Non-Executive Director Large shareholder |
22,053,581
+789.3%
0.91USD 20,068,759 |
22,053,581 +789.3% | 0.91 | USD 20,068,759 | |
| 2022-11-23 | 2022-11-21 | B Purchase | Large shareholder |
150,000
+inf%
0.71USD 106,740 |
150,000 +inf% | 0.71 | USD 106,740 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Large shareholder |
300,694
+4.9%
0.63USD 188,956 |
300,694 +4.9% | 0.63 | USD 188,956 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Large shareholder |
531,000
+9.5%
0.63USD 336,707 |
531,000 +9.5% | 0.63 | USD 336,707 | |
| 2022-11-16 | 2022-11-14 | B Purchase | Large shareholder |
5,608,306
+inf%
0.69USD 3,868,609 |
5,608,306 +inf% | 0.69 | USD 3,868,609 | |
| 2022-11-16 | 2022-11-14 | S Sale | Large shareholder |
3,250,000
-87.6%
0.71USD 2,294,500 |
3,250,000 -87.6% | 0.71 | USD 2,294,500 | |
| 2021-11-29 | 2021-11-24 | B Purchase | Large shareholder |
2,922
+0.1%
5.42USD 15,837 |
2,922 +0.1% | 5.42 | USD 15,837 | |
| 2021-11-23 | 2021-11-22 | B Purchase | Large shareholder |
9,979
+0.3%
5.49USD 54,785 |
9,979 +0.3% | 5.49 | USD 54,785 | |
| 2021-11-23 | 2021-11-19 | B Purchase | Large shareholder |
3,225
+0.1%
5.44USD 17,544 |
3,225 +0.1% | 5.44 | USD 17,544 | |
| 2021-11-12 | 2021-11-11 | B Purchase | Large shareholder |
7,941
+0.2%
6.05USD 48,043 |
7,941 +0.2% | 6.05 | USD 48,043 | |
| 2021-11-12 | 2021-11-10 | B Purchase | Large shareholder |
9,622
+0.3%
5.85USD 56,289 |
9,622 +0.3% | 5.85 | USD 56,289 | |
| 2021-11-10 | 2021-11-08 | B Purchase | Large shareholder |
560
+0.0%
5.99USD 3,354 |
560 +0.0% | 5.99 | USD 3,354 | |
| 2021-11-08 | 2021-11-05 | B Purchase | Large shareholder |
7,800
+0.2%
5.95USD 46,410 |
7,800 +0.2% | 5.95 | USD 46,410 | |
| 2021-11-08 | 2021-11-04 | B Purchase | Large shareholder |
1,400
+0.0%
5.88USD 8,232 |
1,400 +0.0% | 5.88 | USD 8,232 | |
| 2021-11-04 | 2021-11-02 | B Purchase | Large shareholder |
8,880
+0.2%
5.64USD 50,083 |
8,880 +0.2% | 5.64 | USD 50,083 | |
| 2021-11-02 | 2021-10-29 | B Purchase | Large shareholder |
44,651
+1.2%
5.71USD 254,957 |
44,651 +1.2% | 5.71 | USD 254,957 | |
| 2021-10-29 | 2021-10-28 | B Purchase | Large shareholder |
15,082
+0.4%
5.55USD 83,705 |
15,082 +0.4% | 5.55 | USD 83,705 | |
| 2021-10-29 | 2021-10-27 | B Purchase | Large shareholder |
39,581
+1.1%
5.45USD 215,716 |
39,581 +1.1% | 5.45 | USD 215,716 | |
| 2021-10-25 | 2021-10-22 | B Purchase | Large shareholder |
27,629
+0.8%
5.51USD 152,236 |
27,629 +0.8% | 5.51 | USD 152,236 | |
| 2021-10-25 | 2021-10-21 | B Purchase | Large shareholder |
32,816
+0.9%
5.40USD 177,206 |
32,816 +0.9% | 5.40 | USD 177,206 | |
| 2021-10-21 | 2021-10-20 | B Purchase | Large shareholder |
40,663
+1.2%
5.44USD 221,207 |
40,663 +1.2% | 5.44 | USD 221,207 | |
| 2021-10-21 | 2021-10-19 | B Purchase | Large shareholder |
87,580
+2.6%
5.07USD 444,031 |
87,580 +2.6% | 5.07 | USD 444,031 | |
| 2021-10-19 | 2021-10-18 | B Purchase | Large shareholder |
36,194
+1.1%
4.87USD 176,265 |
36,194 +1.1% | 4.87 | USD 176,265 | |
| 2021-10-19 | 2021-10-15 | B Purchase | Large shareholder |
126,000
+3.9%
4.83USD 608,580 |
126,000 +3.9% | 4.83 | USD 608,580 | |
| 2021-03-02 | 2021-02-26 | B Purchase | Non-Executive Director Large shareholder |
1,232,394
+31.4%
5.68USD 6,999,998 |
1,232,394 +31.4% | 5.68 | USD 6,999,998 | |
| 2020-09-03 | 2020-09-01 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-4.7%
22.21USD 22,210 |
1,000 -4.7% | 22.21 | USD 22,210 | |
| 2020-09-03 | 2020-09-01 | PS Planned sale |
Chief Financial Officer Officer |
750
-100.0%
22.19USD 16,645 |
750 -100.0% | 22.19 | USD 16,645 | |
| 2020-08-07 | 2020-08-05 | PS Planned sale |
Chief Financial Officer Officer |
1,000
-100.0%
25.00USD 25,000 |
1,000 -100.0% | 25.00 | USD 25,000 | |
| 2020-08-05 | 2020-08-03 | PS Planned sale |
Chief Medical Officer Officer |
200
-1.0%
23.12USD 4,624 |
200 -1.0% | 23.12 | USD 4,624 | |
| 2020-08-05 | 2020-08-03 | PS Planned sale |
Chief Medical Officer Officer |
800
-3.8%
22.85USD 18,282 |
800 -3.8% | 22.85 | USD 18,282 | |
| 2020-07-02 | 2020-07-01 | PS Planned sale |
Chief Medical Officer Officer |
100
-0.5%
27.81USD 2,781 |
100 -0.5% | 27.81 | USD 2,781 | |
| 2020-07-02 | 2020-07-01 | PS Planned sale |
Chief Medical Officer Officer |
600
-2.9%
26.99USD 16,195 |
600 -2.9% | 26.99 | USD 16,195 | |
| 2020-07-02 | 2020-07-01 | PS Planned sale |
Chief Medical Officer Officer |
300
-1.5%
25.69USD 7,707 |
300 -1.5% | 25.69 | USD 7,707 | |
| 2020-07-02 | 2020-07-01 | PS Planned sale |
Chief Financial Officer Officer |
306
-100.0%
27.59USD 8,444 |
306 -100.0% | 27.59 | USD 8,444 | |
| 2020-07-02 | 2020-07-01 | PS Planned sale |
Chief Financial Officer Officer |
394
-100.0%
26.70USD 10,520 |
394 -100.0% | 26.70 | USD 10,520 | |
| 2020-07-02 | 2020-07-01 | PS Planned sale |
Chief Financial Officer Officer |
300
-100.0%
25.63USD 7,690 |
300 -100.0% | 25.63 | USD 7,690 | |
| 2020-06-24 | 2020-06-23 | PS Planned sale |
Chief Financial Officer Officer |
2,115
-100.0%
35.23USD 74,512 |
2,115 -100.0% | 35.23 | USD 74,512 | |
| 2020-06-02 | 2020-06-01 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-4.7%
25.26USD 25,257 |
1,000 -4.7% | 25.26 | USD 25,257 | |
| 2020-06-02 | 2020-06-01 | PS Planned sale |
Chief Financial Officer Officer |
1,000
-100.0%
25.32USD 25,324 |
1,000 -100.0% | 25.32 | USD 25,324 | |
| 2020-05-21 | 2020-05-20 | PS Planned sale |
Chief Financial Officer Officer |
2,000
-100.0%
25.00USD 50,000 |
2,000 -100.0% | 25.00 | USD 50,000 | |
| 2020-05-06 | 2020-05-05 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-4.7%
20.00USD 20,000 |
1,000 -4.7% | 20.00 | USD 20,000 | |
| 2020-04-16 | 2020-04-14 | PS Planned sale |
Chief Medical Officer Officer |
800
-3.8%
20.00USD 16,000 |
800 -3.8% | 20.00 | USD 16,000 | |
| 2020-04-03 | 2020-04-01 | PS Planned sale |
Chief Medical Officer Officer |
200
-1.0%
20.25USD 4,049 |
200 -1.0% | 20.25 | USD 4,049 | |
| 2020-03-12 | 2020-03-11 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-4.7%
27.42USD 27,422 |
1,000 -4.7% | 27.42 | USD 27,422 | |
| 2020-03-12 | 2020-03-11 | PS Planned sale |
Chief Financial Officer Officer |
1,000
-100.0%
27.68USD 27,678 |
1,000 -100.0% | 27.68 | USD 27,678 | |
| 2019-09-18 | 2019-09-17 | B Purchase |
TPG Group Holdings (SBS) Advisors, Inc. Large shareholder |
100,000
+5.6%
15.00USD 1,500,000 |
100,000 +5.6% | 15.00 | USD 1,500,000 | |
| 2019-09-17 | 2019-09-17 | B Purchase |
233,333
+17.6%
15.00USD 3,499,995 |
233,333 +17.6% | 15.00 | USD 3,499,995 | ||
| 2019-09-17 | 2019-09-17 | B Purchase | Large shareholder |
192,387
+4.3%
15.00USD 2,885,805 |
192,387 +4.3% | 15.00 | USD 2,885,805 | |
| 2019-09-17 | 2019-09-17 | B Purchase | Large shareholder |
1,140,946
+34.1%
15.00USD 17,114,190 |
1,140,946 +34.1% | 15.00 | USD 17,114,190 | |
| 2019-09-17 | 2019-09-17 | B Purchase | Large shareholder |
1,333,333
+39.8%
15.00USD 19,999,995 |
1,333,333 +39.8% | 15.00 | USD 19,999,995 |